Trial NCT00378573

View at ClinicalTrials.gov 
Org. Study IDs: DOCET_L_00730

Last trial update was posted on 2010-01-26

MeSH Interventions

Bevacizumab Docetaxel Gemcitabine

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer

Stopping Reasons

Incidence of GI Perforation

Limitations And Caveats

Due to early termination of the study only 17/90 subjects enrolled. Efficacy analysis of Progression Free Survival and Overall Survival were not performed. Efficacy results limited to a descriptive summary of best overall response for each subject.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID